Also written by Matthew J. Belvedere:
'Nobody at GE is doing a victory lap,' says Nelson Peltz Board Member
x hide permanently

Poison pill won't disrupt Allergan deal: Ackman

Activist investor Bill Ackman told CNBC Tuesday that Allergan's adoption of a poison-pill defense does not necessarily make the takeover bid more difficult...

Mentions: Management Poison Pill Takeover Bid